IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,256,472 | +1.7% | 27,700 | -8.0% | 0.00% | 0.0% |
| Q2 2023 | $1,235,003 | +9.6% | 30,100 | -4.6% | 0.00% | -76.5% |
| Q1 2023 | $1,127,240 | +1.0% | 31,540 | +6.7% | 0.02% | -15.0% |
| Q4 2022 | $1,116,255 | -70.6% | 29,554 | -65.6% | 0.02% | -72.6% |
| Q3 2022 | $3,802,000 | +1511.0% | 85,963 | +1249.7% | 0.07% | +942.9% |
| Q2 2022 | $236,000 | -54.5% | 6,369 | -58.8% | 0.01% | -53.3% |
| Q3 2021 | $519,000 | +4.8% | 15,470 | +88.7% | 0.02% | -53.1% |
| Q4 2019 | $495,000 | -46.0% | 8,200 | -46.4% | 0.03% | -40.7% |
| Q3 2019 | $917,000 | -10.1% | 15,300 | -3.6% | 0.05% | -51.8% |
| Q2 2019 | $1,020,000 | +163.6% | 15,870 | +233.4% | 0.11% | +77.8% |
| Q1 2019 | $387,000 | – | 4,760 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |